other forms of mechanical support, such as durable left ventricular assist devices (dLVAD), which were used in only 4% of patients. As a result of these trial data and meta-analyses, the use of IABP in AMI shock has been downgraded from Class I to Class IIA in the United States (8) and to Class IIB in Europe.
It was also clear that many patients with AMI shock have potentially significant amounts of stunned myocardium that could potentially recover within days post-revascularization, but they need more support than could be provided by the IABP. This gap has led to the development and rapid evolution of entirely new types of mechanical devices that are designed to provide greater temporary mechanical support (TMS) of the circulation (9, 10) . These devices can be From the Morton Plant Mease Foundation, Clearwater, Florida. Dr. Miller has reported that she has no relationships relevant to the contents of this paper to disclose. 
